 GERMANTOWN, Md., March 17, 2021 PRNewswire -- Seneca Biopharma, Inc. Nasdaq: SNCA, today announced that leading independent proxy advisory firm Institutional Shareholder Services, Inc. ISS has recommended that Seneca stockholders vote in support of the proposed merger with Leading BioSciences, Inc. LBS and vote FOR the proposals for the reverse stock split and issuance of shares in connection with the merger, to be considered and voted on at Senecas March 24, 2021 special meeting of stockholders. 